ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Japan drug and chemical makers tap AI for faster development

Astellas, Eisai and Asahi Kasei follow U.S. lead on lab automation

Eisai's systems use AI and robotics to discover and create promising drug candidates in a fraction of the usual time. (Photo courtesy of Eisai)

TOKYO -- More Japanese companies are incorporating artificial intelligence into their research and development in fields like pharmaceuticals and chemicals where overseas rivals have a head start in using AI to speed up breakthroughs.

Astellas Pharma and chemicals group Asahi Kasei are among the companies set to roll out AI-assisted development platforms.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more